Joanne W. Jang, Ph.D.
Affiliations: | 2006 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Joanne Jang"Parents
Sign in to add mentor| Lewis A. Chodosh | grad student | 2006 | Penn | |
| (The contribution of Ras to MYC and Wnt-induced tumor progression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jang JW, Parambi RJ, McBride SM, et al. (2013) Clinical factors predicting for prolonged enteral supplementation in patients with oropharyngeal cancer treated with chemoradiation. Oral Oncology. 49: 438-42 |
| Jang JW, Chan AW. (2013) Prevention and management of complications after radiotherapy for skull base tumors: a multidisciplinary approach. Advances in Oto-Rhino-Laryngology. 74: 163-73 |
| Jang J, Parambi R, Goldsmith T, et al. (2012) Factors Associated With Prolonged Gastrostomy Tube Usage in Patients With Oropharyngeal Cancer Treated With Chemoradiation International Journal of Radiation Oncology*Biology*Physics. 84: S479 |
| Jang JW. (2008) Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor The Korean Journal of Hepatology. 14: 305-308 |
| Jang JW, Boxer RB, Chodosh LA. (2006) Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis. Molecular and Cellular Biology. 26: 8109-21 |
| Boxer RB, Jang JW, Sintasath L. (2005) Persistence of cancer after oncogene targeting Cancer Biology and Therapy. 4 |
| Boxer RB, Jang JW, Sintasath L, et al. (2004) Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell. 6: 577-86 |
| Chodosh L, Boxer R, Moody S, et al. (2003) Reversibility and progression in conditional transgenic mouse models of breast cancer Breast Cancer Research. 5: 5-5 |